Theoretical model for the design and preparation of a CNT–ursonic acid drug matrix as HIV-gp120 entry inhibitor
Human Immunodeficiency Virus (HIV) which infection results into Acquired Immunodeficiency Syndrome (AIDS) has claimed the lives of one half of its 70 million victims, a deadly disease that has attracted a global concern. Major challenges associated with modern HIV drugs include side effects, drug re...
Main Author: | Danlami Umar Zuru |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2019-11-01
|
Series: | Scientific African |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2468227619307380 |
Similar Items
-
Development of Protein- and Peptide-Based HIV Entry Inhibitors Targeting gp120 or gp41
by: Jing Pu, et al.
Published: (2019-08-01) -
Conformation-dependent recognition of HIV Gp120 by DARPins provides novel possibilities to develop distinct HIV entry inhibitors
by: Mann AM, et al.
Published: (2012-09-01) -
Therapeutic Potential of Ursonic Acid: Comparison with Ursolic Acid
by: Juhyeon Son, et al.
Published: (2020-11-01) -
An unprecedented and simple gp120 switch mechanism enables HIV-1 to overcome multiple entry inhibitors and tropism limitations
by: Kabat David, et al.
Published: (2006-12-01) -
Computational study of HIV gp120 as a target for polyanionic entry inhibitors: Exploiting the V3 loop region.
by: Louis R Hollingsworth, et al.
Published: (2018-01-01)